Scottish Health Innovations Ltd (SHIL) works in partnership with NHS Scotland to identify, protect, develop and commercialise new innovations from healthcare professionals. Registered Number: SC 236303. Registered address: The Golden Jubliee National Hospital, Fourth Floor East, Agmemmon St, Clydebank, G81 4DY
CardioPrecision
CardioPrecision has developed an innovative and patented technology that allows clinicians to perform minimally invasive intervention through a short transverse incision to the neck. Key benefits include much less pain and faster recovery than current approaches. Secondary benefits may include reduced blood loss, lower rates of transfusion/infection and much shorter hospital stay. The technology aims to provide both improved clinical outcome for patients and economic savings for healthcare providers.
CardioPrecision’s Single-Use CoreVista® Retractor and CoreVista® Accessories allows cardiothoracic surgery to be performed through a short incision in the skin crease of the neck.
CoreVista® technology has been used to implant structureless valves into the aortic position. The HD monitor, which is conspicuously positioned directly above the incision and covered by a sterile disposable monitor drape, provides the surgeon with a magnified view of the operative field.